alpine clenz unscented wipes- benzalkonium chloride 0.3% swab
alpine industries - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available on children less than 2 months of age on open skin wounds if irritation or rash occurs. these may be signs of a serious condition.
cable/lead, electroencephalograph
medtronic australasia pty ltd - 35749 - cable/lead, electroencephalograph - the cable is used for the transmission of electrical signals from the patient's brain to the electroencephalograph (eeg) machine.
patient monitor, electroencephalograph
medtronic australasia pty ltd - 35196 - patient monitor, electroencephalograph - the electroecephalograph processes and displays electrical signals produced by the patients brain.
see full oil
alpine medical industries sdn. bhd. - camphor; methyl salicylate; menthol -
xience alpine everolimus eluting coronary stent system - drug-eluting coronary artery stent, non-biodegradable-polymer-coated
abbott vascular division of abbott medical australia pty ltd - 56284 - drug-eluting coronary artery stent, non-biodegradable-polymer-coated - xience alpine is a pre-mounted l-605 cobalt chromium (cocr) alloy stent with a coating that consists of a blend of the anti-proliferative drug everolimus and polymers. two radiopaque markers, located underneath the balloon, fluoroscopically mark the working length of the balloon and the expanded stent length. two proximal delivery system shaft markers indicate relative position of delivery system to the end of the brachial or femoral guiding catheter. the xience alpine? everolimus eluting coronary stent system is indicated for improving coronary artery luminal diameter in the following: ? patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. ? for restoring coronary flow in patients experiencing acute myocardial infarction who present within 12 hours of symptom onset. ? for the treatment of patients with concomitant diabetes, acute coronary syndrome, dual vessel lesions (two lesions in two different epicardial vessels), lesions residing within small coronary vessels; lesions where treatment results in the jailing of side branches (lesions with a side branch < 2 mm in diameter or an ostial stenosis < 50%); for the treatment of elderly patients (age ? 65), and for treatment of both men and women. ? for treatment of patients with high bleeding risk (hbr) under dual antiplatelet therapy (dapt) as short as 28 days. for the treatment of patients presenting with in-stent restenosis in coronary artery lesions; chronic total occluded coronary artery lesions (defined as coronary artery lesions with timi flow 0 and lasting longer than 3 months); and coronary artery bifurcation lesions. in all cases, the treated lesion length should be less than the nominal stent length (8 mm, 12 mm, 15 mm, 18 mm, 23 mm, 28 mm, 33 mm, or 38 mm) with a reference vessel diameter of ? 2.00 mm and ? 4.25 mm.
fragaria vesca- alpine strawberry pellet
boiron - alpine strawberry (unii: cg6ix3gcmu) (alpine strawberry - unii:cg6ix3gcmu) - hives* stop use and ask a doctor if symptoms persist for more than 3 days or worsen
fragaria vesca- alpine strawberry pellet
boiron - alpine strawberry (unii: cg6ix3gcmu) (alpine strawberry - unii:cg6ix3gcmu) - hives* stop use and ask a doctor if symptoms persist for more than 3 days or worsen
royalpine-10 10 mg oral solid ordinary film-coated tablets
synokem pharmaceuticals limited - amlodipine besylate - oral solid ordinary film-coated tablets - 10 mg
royalpine-5 5 mg oral solid ordinary film-coated tablets
synokem pharmaceuticals limited - amlodipine besylate - oral solid ordinary film-coated tablets - 5 mg
calpine 5mg tablet
suhitas pharmaceuticals inc.; distributor: suhitas pharmaceuticals inc. - amlodipine (as besilate) - tablet - 5mg